Table 2. Liver Function Parameters and Changes in Prothrombin Activity Before and After Treatment^a.

Group	0-Week	12th Week	24th Week	36th Week	48th Week	Number
Treatment group						33
TBil, mol/L	55.20 ± 38.95	54.33 ± 34.34	53.31 ± 36.93	56.35 ± 32.70	52.52 ± 33.29
Alb, g/L	30.10 ± 3.75	31.46 ± 4.23	32.82 ± 5.10b	34.02 ± 3.60b	34.70 ± 3.80b
PTA, %	50.09 ± 6.56	53.39 ± 9.20b	55.58 ± 9.53b	57.39 ± 7.44b	58.15 ± 8.11b
MELD score	12.94 ± 1.92	12.27 ± 3.63	12.12 ± 3.41	12.12 ± 3.13	11.30 ± 3.08c
Control group,						35
TBil, mol/L	60.24 ± 35.56	56.63 ± 30.44	55.89 ± 36.07	57.18 ± 28.69	55.23 ± 31.32
Alb, g/L	28.75 ± 8.20	29.11 ± 6.19	29.16 ± 6.13d	30.87 ± 5.11d	30.58 ± 5.43d
PTA, %	46.77 ± 10.32	48.09 ± 10.87	48.29 ± 10.78c	50.34 ± 7.91c	50.09 ± 8.01c
MELD score	13.57 ± 1.96	13.66 ± 3.26	13.43 ± 3.24	13.31 ± 3.73	13.31 ± 2.44d

^aValues are presented as mean ± SD.

^bP < 0.05, compared to before treatment.

^cP < 0.01, compared to the control group.

^dP < 0.05, compared to the control group.